PRESS RELEASES More events are coming soon. Keyword Search Year: 20202019201820172016201520142013 09/21/20 Summary ToggleTRACON Pharmaceuticals Highlights Updated Envafolimab Clinical Results in MSI-H/dMMR Colorectal Cancer Printer Friendly PDF Version 09/10/20 Summary ToggleTRACON Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference Printer Friendly PDF Version 09/03/20 Summary ToggleTRACON Pharmaceuticals to Present at the Wells Fargo Virtual Healthcare Conference Printer Friendly PDF Version 08/31/20 Summary ToggleTRACON Pharmaceuticals Announces Additional $5.0 Million Private Placement Printer Friendly PDF Version 08/27/20 Summary ToggleTRACON Pharmaceuticals Announces $5.0 Million Private Placement Printer Friendly PDF Version 08/17/20 Summary ToggleTRACON Pharmaceuticals Announces FDA Clearance of ENVASARC Pivotal Trial Printer Friendly PDF Version 08/05/20 Summary ToggleTRACON Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update Printer Friendly PDF Version 08/03/20 Summary ToggleTRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference Printer Friendly PDF Version 07/29/20 Summary ToggleTRACON to Report Second Quarter 2020 Financial Results and Company Highlights on August 5, 2020 Printer Friendly PDF Version 07/16/20 Summary ToggleTRACON Pharmaceuticals Announces Filing of Protocol for ENVASARC Pivotal Trial with the FDA Printer Friendly PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
